Crypts in Asymmetric Branching in Patients With Ulcerative Colitis in Remission

被引:0
|
作者
Rubio, Carlos A. [1 ,2 ]
Vieth, Michael [3 ]
Lang-Schwarz, Corinna [4 ]
机构
[1] Karolinska Inst, Dept Pathol, Stockholm, Sweden
[2] Univ Hosp, S-17176 Stockholm, Sweden
[3] Friedrich Alexander Univ Erlangen Nuremberg, Bayreuth, Germany
[4] Klinikum Bayreuth, Inst Pathol, Bayreuth, Germany
关键词
Key Words; Colon biopsies; crypts; asymmetric branching; ulcerative colitis; remission; INFLAMMATORY-BOWEL-DISEASE; ENDOSCOPIC BIOPSIES; RECTAL BIOPSY; FISSION; SPECIMENS;
D O I
10.21873/anticanres.15950
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: To report the frequency of crypts in asymmetric branching (CAB) in biopsies from all colorectal segments in patients with ulcerative colitis in remission (UCR). Patients and Methods: Biopsies in 100 UC patients were investigated: 50 with UCR and 50 with ongoing long-lasting UC (LLU; i.e., controls). Results: The frequency of CAB was significantly lower in UCR than in LLUC, both in the right colon and left colorectum. CAB frequency was not influenced by two important confounders: the age and sex of patients. Conclusion: CAB is a pathologic aberration of colorectal cryptogenesis evoked by chronic mucosal inflammation. When chronic inflammation waned in UCR, the production of CAB plummeted or ceased. Chronic inflammation and protracted disease-duration in LLUC increase the risk for colorectal dysplasia or carcinoma. Importantly, dysplastic CAB were recently detected in LLUC-associated dysplasia. Whether the abrogation of CAB is instrumental in reducing the neoplastic risk in UCR patients, deserves further investigation.
引用
收藏
页码:4493 / 4497
页数:5
相关论文
共 50 条
  • [21] Is maintenance therapy always necessary for patients with ulcerative colitis in remission?
    Ardizzone, S
    Imbesi, V
    Molteni, P
    Bollani, S
    Porro, GB
    [J]. TRENDS IN INFLAMMATORY BOWEL DISEASE THERAPY 1996, 1997, : 279 - 280
  • [22] Germinated barley foodstuff prolongs remission in patients with ulcerative colitis
    Hanai, H
    Kanauchi, O
    Mitsuyama, K
    Andoh, A
    Takeuchi, K
    Takayuki, I
    Araki, Y
    Fujiyama, Y
    Toyonaga, A
    Sata, M
    Kojima, A
    Fukuda, M
    Bamba, T
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 13 (05) : 643 - 647
  • [23] Predictors of Endoscopic Inflammation in Patients With Ulcerative Colitis in Clinical Remission
    Rosenberg, Laura
    Lawlor, Garrett O.
    Zenlea, Talia
    Goldsmith, Jeffrey D.
    Gifford, Anne
    Falchuk, Kenneth R.
    Wolf, Jacqueline L.
    Cheifetz, Adam S.
    Robson, Simon C.
    Moss, Alan C.
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) : 779 - 784
  • [24] Evaluation of histological parameters in patients with clinical remission of ulcerative colitis
    Kondrashina, E.
    Schukina, O.
    Kharitidis, A.
    Botina, A.
    Markova, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S214 - S214
  • [25] Budesonide MMX and Mesalamine to Induce Remission in Patients With Ulcerative Colitis
    Criscuoli, Valeria
    Sinagra, Emanuele
    Cottone, Mario
    [J]. GASTROENTEROLOGY, 2013, 144 (03) : E23 - E23
  • [26] Histologic improvement predicts endoscopic remission in patients with ulcerative colitis
    Kim, Ji Eun
    Kim, Minjee
    Kim, Min-Ji
    Kim, Eun Ran
    Hong, Sung Noh
    Chang, Dong Kyung
    Ha, Sang Yun
    Kim, Young-Ho
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] HISTOLOGICAL REMISSION DOSE NOT OFFER ADDITIONAL BENEFIT FOR ULCERATIVE COLITIS PATIENTS IN ENDOSCOPIC REMISSION
    Alshahrani, Abdulaziz S.
    Alsaedi, Mona
    Fadida, Ma'ayan
    Narula, Neeraj
    Marshall, John K.
    Rubin, David T.
    Christensen, Britt
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S940 - S940
  • [28] Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission
    Narula, Neeraj
    Aruljothy, Achuthan
    Alshahrani, Abdul-Aziz
    Fadida, Ma'ayan
    Al-Saedi, Mona
    Marshall, John K.
    Rubin, David T.
    Christensen, Britt
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (11-12) : 1676 - 1682
  • [29] Histological remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission
    Narula, N.
    Alshahrani, A. A.
    Fadida, M.
    Al-Saedi, M.
    Marshall, J. K.
    Rubin, D. T.
    Christensen, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S519 - S520
  • [30] Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
    Pop, Corina Silvia
    Filip, Petruta Violeta
    Diaconu, Sorina Laura
    Matei, Clara
    Furtunescu, Florentina
    [J]. MEDICINA-LITHUANIA, 2021, 57 (01):